Urinary Bladder Neoplasms: all 1,649 studies
Page 11 of 17. Open to participants first (427), then studies with results posted, then the rest; newest registration first within each.
- Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial CarcinomaCompletedNCT04314245
- Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin FailureCompletedNCT04311580Phase 2
- Microscopic-spectroscopic Examination for Urothelial Tissue CharacterizationCompletedNCT04310813
- Use of Pedometer Following Radical CystectomyStatus unknownNCT04305730Not applicable
- Skipping BCG for T1a Urinary Bladder Tumor.Status unknownNCT04298073
- Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr CancerActive, not recruitingNCT04289779Phase 2
- Metadherin mRNA Expression in Bladder CancerStatus unknownNCT04286672
- Early Intervention for Impairments Identified During Comprehensive Geriatric Assessment in Patients With Bladder CancerTerminatedNCT04273724Not applicable
- A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersTerminatedNCT04260802Phase 1/2
- Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder CancerStatus unknownNCT04256616
- Measurements of Sexual Steroids' Concentrations in Prostatic TissueCompletedNCT04256161
- Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or ImmunotherapyStatus unknownNCT04256122
- A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerTerminatedNCT04254107Phase 1
- Neoadjuvant Chemotherapy in Non Muscle Invasive T1b Bladder CancerStatus unknownNCT04245618
- Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)Active, not recruitingNCT04241185Phase 3
- Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary MalignanciesActive, not recruitingNCT04235777Phase 1
- Safety and Efficacy of Bipolar vs Monopolar Transurethral Resection of Bladder Tumor-A Randomized Controlled TrialCompletedNCT04234165Not applicable
- Effect of Head Elevation on LMA InsertionCompletedNCT04229862Not applicable
- Protocol of the Italian Radical Cystectomy RegistryStatus unknownNCT04228198
- Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility StudyStatus unknownNCT04223063Not applicable
- Evaluation of Naloxegol in the Prevention of POI After CystectomyWithdrawnNCT04219046Phase 2
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE TrialActive, not recruitingNCT04216290Phase 2
- Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)CompletedNCT04212403Not applicable
- A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial CarcinomaCompletedNCT04200963Phase 1
- Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective StudyCompletedNCT04194112Not applicable
- Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncerActive, not recruitingNCT04186013Phase 2
- Treatment of Recurrent Bladder Cancer With Dendritic CellsCompletedNCT04184232Phase 2
- Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 ExpressionActive, not recruitingNCT04180371Phase 1/2
- Can VI-RADS/ADC Accurately Stage Bladder Cancer??Active, not recruitingNCT04167631Not applicable
- Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder CancerActive, not recruitingNCT04164082Phase 2
- EpiCheck and Short-term Intensive Chemoresection in NMIBCStatus unknownNCT04162704
- New Technique for Uretero-ileal Anastomosis for Patient With Bladder Cancer Who Are Suitable for Orthotopic NeobladderCompletedNCT04162093Not applicable
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsCompletedNCT04157985Phase 3
- Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria PatientsActive, not recruitingNCT04155359
- Protoves M1® Syrup in Controlling Adverse Event During HIVEC® InstillationsStatus unknownNCT04148677
- The Importance of Muscle Function in Patients With Disseminated Bladder CancerStatus unknownNCT04144270
- Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical CystectomyActive, not recruitingNCT04138628Phase 2
- Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)Active, not recruitingNCT04134000Phase 1
- Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudyStatus unknownNCT04129606Not applicable
- Low-moderate Intensity Pedaling During Immunotherapy AdministrationWithdrawnNCT04127318Not applicable
- Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder CancerCompletedNCT04110483Not applicable
- A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102WithdrawnNCT04109092Phase 1
- Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder CancerStatus unknownNCT04101812Phase 2
- Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer MonitorActive, not recruitingNCT04100733Not applicable
- Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial CarcinomaStatus unknownNCT04099589Phase 2
- Basal Tumours in Bladder Cancer, Response to chemoTherapyCompletedNCT04089748
- A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)WithdrawnNCT04089163Phase 1
- Transurethral Modified En Bloc Resection For Large Bladder Tumours.CompletedNCT04081246Not applicable
- TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder CancerWithdrawnNCT04073160Phase 1
- Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerStatus unknownNCT04060459Phase 2
- Vaccine Response With NT-I7WithdrawnNCT04054752Phase 1
- Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 OverexpressionWithdrawnNCT04040725Phase 2
- Mood Disorders Bladder CancerCompletedNCT04036877
- Laser vs. Electorsurgical Enbloc Resection of Bladder TumoursStatus unknownNCT04029948Not applicable
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial CarcinomaActive, not recruitingNCT04004442Phase 1
- Physical Rehabilitation Among Patients Undergoing Radical Cystectomy Due to Urinary Bladder CancerCompletedNCT03998579Not applicable
- Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing CystectomyStatus unknownNCT03993249Phase 2
- Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine CarcinomaStatus unknownNCT03992911Phase 2/3
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as ProphylaxisStatus unknownNCT03982797Phase 2
- Study Comparing Open Radical Cystectomy With Robot-assisted Cystectomy in Patients With Bladder CancerCompletedNCT03977831Not applicable
- Urine-based Detection of Non-muscle Invasive BladderCompletedNCT03962933
- Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder CancerStatus unknownNCT03950362Phase 2
- Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)CompletedNCT03924856Phase 3
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2
- A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsCompletedNCT03914794Phase 2
- Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective StudyStatus unknownNCT03914001Not applicable
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Circulatory Function in Laparoscopic Radical Cystectomy for Bladder CancerCompletedNCT03892031
- A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsCompletedNCT03872947Phase 1
- Simulation in Transurethral Bladder Cancer SurgeryStatus unknownNCT03864302Not applicable
- Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder TumorsCompletedNCT03863028
- Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder CancerCompletedNCT03862105Not applicable
- A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder CancerCompletedNCT03854721Phase 1
- Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial CarcinomaActive, not recruitingNCT03854474Phase 1/2
- Mind-Body Health in Uro-Oncology: Research StudyCompletedNCT03852030Not applicable
- Continuous Bladder Irrigation Following Transurethral Resection of Bladder TumorsWithdrawnNCT03839472Not applicable
- (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial CancerActive, not recruitingNCT03837821Early Phase 1
- Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR StudyWithdrawnNCT03832673Phase 2
- hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"Status unknownNCT03824691Phase 2
- A Clinical Trial of Extraperitonealization for Prevention of Parastomal Hernia After Ileal ConduitCompletedNCT03822234Not applicable
- Implementation of Nutrition Education Videos for Patients Undergoing Radical CystectomyCompletedNCT03801954
- An Expanded Access Study of Bemarituzumab (FPA144) for a Single Patient With Recurrent Bladder CancerNo longer availableNCT03801278
- Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer PatientsActive, not recruitingNCT03799835Phase 3
- Expression of MCM5 in Urine in Patients With Urothelial CancersStatus unknownNCT03796299
- Sequential Combination Therapy in Bladder CancerStatus unknownNCT03790384Phase 4
- CD155 in Bladder CancerCompletedNCT03789682
- Adjuvant Chemotherapy for Biliary Tract Cancer After Curative ResectionStatus unknownNCT03779035Phase 3
- Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder CancerActive, not recruitingNCT03775265Phase 3
- A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)CompletedNCT03773666Phase 1
- Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder CancerActive, not recruitingNCT03768570Phase 2
- A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder CancerStatus unknownNCT03762161Phase 2
- Efficacy of Durvalumab in Non-muscle-invasive Bladder CancerStatus unknownNCT03759496Phase 2
- Multidisciplinary Bladder-preservation Therapy for Bladder CancerStatus unknownNCT03756207Not applicable
- Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer PatientsStatus unknownNCT03739177
- En-bloc vs Conventional Resection of Primary Bladder TumorCompletedNCT03718754Phase 3
- Prospective Study of Adjuvant Radiotherapy in High Risk Bladder Cancer.TerminatedNCT03718741Not applicable
- Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation StudyCompletedNCT03715660Not applicable
- Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical CystectomyActive, not recruitingNCT03697850Phase 2
- Intravesical Thermochemotherapy With Mitomycin-cCompletedNCT03694535Not applicable